SADDLE BROOK, N.J.,
Feb. 7, 2012 /PRNewswire/ --
Herborium Group, Inc., (Pink Sheets: HBRM) www.herborium.com, a
Botanical Therapeutics® company, announces
today its plan to launch an aggressive Investors Awareness Campaign
beginning Feb. 7th 2012 to continue
throughout 2012. Strategies and programs are designed to increase
mass market awareness of the Company among individual investors,
institutions, analysts along with financing injections.
Dr. Agnes Olszewski, Chairmen and
CEO of Herborium stated: "We are most excited to confirm that we
are beginning the next step in our business plan to foster
growth and to increase shareholder value and trading volume.
Also, as a part of growing our market presence and sales we have
announced 2012 - Year Without Acne.
"Our Social Media Strategy that commenced in Summer of 2011 is
already bringing results. Our 2011 Internet sales grew
6.5%. Number of our twitter followers doubled since
December 2011 and we have scheduled
numerous Social Media events on our own and with new partners to
keep the momentum going. We will share those developments
with our shareholders in upcoming weeks.
"AcnEase®, www.acnease.com, our unique all botanical
therapeutic® for Acne is gaining a strong following. Over
130 million people are affected by Acne in the US and Europe alone. Herborium's
AcnEase® results are very impressive, with up to 95%
of both females and males seeing significant improvement after the
first course of treatment," added Dr. Olszewski.
"In addition to progress in brand building and growing sales of
AcnEase Herborium is developing
platform to develop sales of its other Botanical Therapeutics®
"We have a number of existing, proprietary, patented, or trade
secret protected, natural medicinal products that are uniquely
qualified to address highly important health concerns.
"During the recent months significant progress has been made to
identify a proper partners and distribution channels in the US and
abroad to commercialize those products," concluded
Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to
establish and maintain a differential advantage. The company
sales its products in the US and Europe. For more information, please visit
www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends."
We cannot promise future returns. Our statements reflect our
best judgment at the time, and we disclaim any obligation to update
or alter forward-looking statements as the result of new
information or future events. The Company urges
investors to review the risks and uncertainties contained within
its filings with the OTC Markets and/or Securities and Exchange
Commission.
For more information please inquire:
Herborium Group, Inc.
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.